Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;25(6):2000082.
doi: 10.2807/1560-7917.ES.2020.25.6.2000082. Epub 2020 Feb 11.

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020

Chantal B E M Reusken  1   2 , Eeva K Broberg  3 , Bart Haagmans  2 , Adam Meijer  1 , Victor M Corman  4   5 , Anna Papa  6 , Remi Charrel  7 , Christian Drosten  4   5 , Marion Koopmans  2 , Katrin Leitmeyer  3 ; EVD-LabNet and ERLI-Net  8
Affiliations

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020

Chantal B E M Reusken et al. Euro Surveill. 2020 Feb.

Abstract

Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.

Keywords: 2019-nCoV; coronavirus; emerging infections; laboratory; response; zoonoses.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Time-line with hallmark events of the first two months of the novel coronavirus (2019-nCoV) outbreak, December 2019–January 2020
Figure 2
Figure 2
Status of availability of molecular diagnostics for novel coronavirus (2019-nCoV) in EU/EEA countries as at 29 January 2020 (n = 46 laboratories)a
Figure 3
Figure 3
Diagnostic capacity of specialised laboratories with molecular tests available or forthcoming for novel coronavirus (2019-nCoV), EU/EEA, January 2020 (n = 46)a
Figure 4
Figure 4
Challenges reported by laboratories in terms of implementing molecular diagnostics for novel coronavirus (2019-nCoV), EU/EEA, January 2020 (n = 47)
See this image and copyright information in PMC

References

    1. Tan WJ, Zhao X, Ma XJ, Wang W, Niu P, Xu W, et al. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China 2019−2020. China CDC Weekly. 2020;2:61-2. - PMC - PubMed
    1. Novel 2019 coronavirus genome. [Accessed 02 Feb 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319
    1. European Centre for Disease Control and Prevention (ECDC). Novel coronavirus. Stockholm: ECDC. [Accessed 11 Feb 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus-china
    1. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;NEJMc2001468. 10.1056/NEJMc2001468 - DOI - PMC - PubMed
    1. World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: WHO; 30 Jan 2020. [Accessed 01 Feb 2020], Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...

MeSH terms